Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe.

TitleDetection of dysplastic intestinal adenomas using a fluorescent folate imaging probe.
Publication TypeJournal Article
Year of Publication2005
AuthorsChen W-T, Khazaie K, Zhang G, Weissleder R, Tung C-H
JournalMol Imaging
Volume4
Issue1
Pagination67-74
Date Published2005 Jan-Mar
ISSN1535-3508
KeywordsAdenoma, Animals, Antigens, Differentiation, Carrier Proteins, Flow Cytometry, Fluorescent Dyes, Folate Receptors, GPI-Anchored, Folic Acid, Genes, APC, Intestinal Neoplasms, Macrophage-1 Antigen, Macrophages, Mice, Mice, Mutant Strains, Receptors, Cell Surface
Abstract

Macrophages have long been recognized as a prominent component of tumors. Activated macrophages overexpress folate receptors and we used this phenomenon to image inflammatory reactions in colon dysplasia using a fluorescent folate probe (FFP). APC(Delta468) mice injected with FFP showed fluorescent adenomas (target-to-background ratio, adenoma vs. adjacent normal mucosa, of 2.46 +/- 0.41), significantly higher (p < .001) than adenomas in animals injected with a non-folate-containing control probe. Fluorescence-activated cell-sorting analysis revealed a 3-fold higher content of Mac1-positive cells in colonic adenomas compared with normal adjacent mucosa (6.8% vs. 2.2%), and confirmed the source of FFP-positive cells to be primarily an F4/80-positive macrophage subpopulation. Taken together, these results indicate that probe potentially can be used to image dysplastic intestinal adenomas in vivo.

Alternate JournalMol Imaging
PubMed ID15967128
Grant ListP50 CA 86355 / CA / NCI NIH HHS / United States
R01 CA 104547-01A1 / CA / NCI NIH HHS / United States
R01 CA 99385 / CA / NCI NIH HHS / United States
R33 CA 88365 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065